ASTM F2997-21 PDF
Standard Practice for Quantification of Calcium Deposits in Osteogenic Culture of Progenitor Cells Using Fluorescent Image Analysis
Standard Practice for Quantification of Calcium Deposits in Osteogenic Culture of Progenitor Cells Using Fluorescent Image Analysis
- Статус документа:
- Действующий
- Формат:
- Электронный (PDF)
- Количество страниц:
- 17
- Дата публикации:
- 15 июня 2021 г.
- Издание:
- F2997
- ICS:
- 07.100.10
SIGNIFICANCE AND USE 5.1 In-vitro osteoblast differentiation assays are one approach to screen progenitor stem cells for their capability to become osteoblasts. The extent of calcium deposits or mineralized matrix that form in vitro may be an indicator of differentiation to a functional osteoblast; however, expression of osteogenic genes or proteins is another important measurement to use in conjunction with this assay to determine the presence of an osteoblast. 5.2 This practice provides a technique for staining, imaging, and quantifying the fluorescence intensity and area related to the mineralization in living cell cultures using the non-toxic calcium-chelating dye, XO. The positively stained area of mineralized deposits in cell cultures is an indirect measure of calcium content. It is important to measure the intensity to ensure that the images have not been underexposed or overexposed. Intensity and area do not correlate directly to calcium content. 5.3 XO enables the monitoring of calcium deposits repeatedly throughout the life of the culture without detriment to the culture. There is no interference on subsequent measurements of the mineralized area due to dye accumulation from repeated application (1).3 Calcium deposits that have been previously stained may appear brighter, but this does not impact the area measurement. Calcein dyes may also be used for this purpose (1) but require a different procedure for analysis than XO (that is, concentration and filter sets) and are thus not included here. Alizarin Red and Von Kossa are not suitable for use with this procedure on living cultures since there is no documentation supporting their repeated use in living cultures without deleterious effects. 5.4 The practice may be applied to cultures of any cells capable of producing calcium deposits. It may also be used to document the absence of mineral in cultures where the goal is to avoid mineralization. 5.5 During osteoblast differentiation assays, osteogenic supplements are ... SCOPE 1.1 This practice defines a method for the estimation of calcium content at multiple time points in living cell cultures that have been cultured under conditions known to promote mineralization. The practice involves applying a fluorescent calcium-chelating dye that binds to the calcium phosphate mineral crystals present in the live cultures followed by image analysis of fluorescence microscopy images of the stained cell cultures. Quantification of the positively stained areas provides a relative measure of the calcium content in the cell culture plate. A precise correlation between the image analysis parameters and calcium content is beyond the scope of this practice. 1.2 Calcium deposition in a secreted matrix is one of several features that characterize bone formation (in vitro and in vivo), and is therefore a parameter that may indicate bone formation and osteoblast function (that is, osteoblastic differentiation). Calcium deposition may, however, be unrelated to osteoblast differentiation status if extensive cell death occurs in the cell cultures or if high amounts of osteogenic medium components that lead to artifactual calcium-based precipitates are used. Distinguishing between calcium deposition associated with osteoblast-produced mineralized matrix and that from pathological or artifactual deposition requires additional structural and chemical characterization of the mineralized matrix and biological characterization of the cell that is beyond the scope of this practice. 1.3 The parameters obtained by image analysis are expressed in relative fluorescence units or area percentage (area%), for example, fraction of coverage of the area analyzed. 1.4 Units—The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibili...
Abstract
Overview
ASTM F2997-21 is an international standard developed by ASTM International under Committee F04 on Medical and Surgical Materials and Devices. Titled "Standard Practice for Quantification of Calcium Deposits in Osteogenic Culture of Progenitor Cells Using Fluorescent Image Analysis," this practice outlines a reproducible method for estimating calcium content in living cell cultures, typically for bone tissue engineering and stem cell research. The standard specifically utilizes a non-toxic, calcium-chelating fluorescent dye (xylenol orange, XO) for staining, imaging, and visual quantification of mineralized calcium deposits during in-vitro osteoblast differentiation assays.
Key Topics
- In-vitro Osteoblast Differentiation: The standard is used to monitor the mineralization process as progenitor cells differentiate into osteoblasts, characterized by the deposition of calcium phosphate within a secreted extracellular matrix.
- Fluorescent Image Analysis: Employs fluorescence microscopy and digital image analysis to quantify both the area and intensity of positively stained calcium deposits, providing a relative measure of mineralization.
- Non-Toxic, Repeatable Staining: XO dye allows for repeated monitoring of live cultures without negative impact, enabling longitudinal studies across multiple time points.
- Standardization and Calibration: Recommends using certified fluorescent bead standards and standardized imaging protocols to ensure reliability and comparability across laboratories and experimental setups.
- Normalization Parameters: Results can be expressed as relative fluorescence units or percent area, and can also be normalized to total DNA content to account for differences in cell proliferation.
Applications
This ASTM standard offers significant practical value to researchers and clinicians in the fields of tissue engineering, stem cell biology, orthopedics, and bone regeneration. Key application areas include:
- Bone Tissue Engineering Research: Allows scientists to screen and compare the osteogenic differentiation potential of various progenitor or stem cell types by quantifying mineralization in vitro.
- Stem Cell Quality Control: Supports consistent assessment of stem cell-based therapy products by establishing reproducible and non-destructive mineralization assays.
- Biomedical Device Testing: Assists developers of scaffolds and biomaterial substrates in evaluating the osteoinductive properties of their products through standardized imaging protocols.
- Reduction of Animal Testing: Provides an advanced in-vitro alternative for mineralization analysis, supporting reduction and replacement initiatives in biomedical research.
- Longitudinal Experimentation: By enabling repeat measurements on living cultures, researchers can track dynamic changes in mineralization over time without compromising cell viability.
Related Standards
Practitioners using ASTM F2997-21 may also find value in the following related documents:
- ASTM F2312: Terminology Relating to Tissue Engineered Medical Products
- ASTM F3294: Guide for Performing Quantitative Fluorescence Intensity Measurements in Cell-based Assays with Widefield Epifluorescence Microscopy
- ASTM F2739: Guide for Quantifying Cell Viability and Related Attributes within Biomaterial Scaffolds
These supporting standards provide complementary guidance for terminology, image analysis methods, intensity calibration, and viability assessment, contributing to the robustness and reliability of cell-based mineralization assays.
Employing ASTM F2997-21 ensures that laboratories can perform standardized, non-destructive quantification of calcium deposits, supporting advancements in stem cell research, tissue engineering, and the development of bone regenerative therapies. This consistent framework strengthens comparability and reproducibility, ultimately accelerating innovations in biomaterials and regenerative medicine.
Технические детали
- Технический комитет
- F04 - Medical and Surgical Materials and Devices
- SKU
- ASTM F2997-21
Похожие стандарты
Другие стандарты ASTM
ASTM-TPT-47
Phase I & Phase II Environmental Site Assessment Processes
Phase I & Phase II Environmental Site Assessment Processes
ASTM-TPT-8
Phase I Environmental Site Assessment Practices For Commercial Real Estate: Phase I Site Assessment & Transac…
ASTM-TPT-1137
ASTM D975 Standard Specification for Diesel Fuel
ASTM D975 Standard Specification for Diesel Fuel
ASTM-TPT-1202
ASTM D8421 Standard Test Method for Determination of Per- and Polyfluoroalkyl Substances (PFAS) in Aqueous Ma…
ASTM D8421 Standard Test Method -- eLearning Course
ASTM-TPT-691
Microaprendizagem para D4057: Amostragem de ponto (PT)
D4057 Microlearning: Spot Sampling Portuguese
ASTM-TPT-1091
Metodo de prueba estandar D4052 de ASTM -- Curso de aprendizaje electrónico (ES)
Modulo eLearning para ASTM D4052 en espanol
ASTM ACEM20180086
Using Neutron Radiography to Quantify the Settlement of Fresh Concrete
Specifications have been implemented for concrete bridge decks in North America that restrict the use of higher slump concrete mixtures primarily because of concerns about differential settlement and…
ASTM ACEM20180041
Experimental Study of Competing Failure of Reinforced Concrete Based on the Weibull Distribution
To predict the failure lifetime of reinforced concrete, a current accelerating corrosion test was performed on concrete by simulating the environment in an area with saline soil. To study the concret…